Please use a PC Browser to access Register-Tadawul
Get It
Reported Earlier, MAIA Biotechnology Raises $30M Through 20M Common Share Public Offering At $1.50 Per Share To Fund Cancer Immunotherapy Clinical Trials
MAIA Biotechnology, Inc. MAIA | 1.53 | -2.55% |
